Immunological look at the treatment of coronavirus COVID-19 and SARS-2 infections
Published: 30 March 2020
Likarska sprava pp 3-7; doi:10.31640/jvd.1-2.2020(1)
Abstract: The article outlines the causes of deaths when using a combination of azithromycin with Plaquenil®. Immunological substantiation of the main factors leading to vascular and pulmonary pathology (triggering angiotensin-converting enzyme and helper aggression in the lungs) is given. An immunotherapy method that eliminates the etiological links of the processes occurring during COVID-19 viremia is proposed. The method of prophylaxis of personnel in contact with patients is to use specific antibodies to coronaviruses found in immunoglobulin with intramuscular injection. A treatment schema for severe patients with COVID-19, SARS-2 is proposed.
Keywords: Treatment / Antibodies / prophylaxis / lungs / azithromycin / Coronavirus / Substantiation / Vascular / Converting / COVID
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Click here to see the statistics on "Likarska sprava" .